News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Rosetta Biosoftware Licenses the Rosetta Resolver® Gene Expression Data Analysis System to the University of California, Los Angeles (UCLA)
February 26, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SEATTLE & LOS ANGELES--(BUSINESS WIRE)--Rosetta Biosoftware announced today that the University of California, Los Angeles (UCLA) licensed the Rosetta Resolver® system to support research at UCLA's Jonsson Comprehensive Cancer Center (JCCC).
Twitter
LinkedIn
Facebook
Email
Print
Alliances
MORE ON THIS TOPIC
Mergers & acquisitions
Novartis Continues Hunt for New Assets With Rumored Takeover of RNA Specialist Avidity
August 7, 2025
·
2 min read
·
Tristan Manalac
Earnings
Lilly Faces Triple Threat of Drug Pricing Pressure as CEO Emphasizes Value
August 7, 2025
·
3 min read
·
Annalee Armstrong
Cancer
Big Pharma-Backed mRNA Startup Bags $153M Series B Amid Policy Headwinds
August 7, 2025
·
2 min read
·
Tristan Manalac
Earnings
Despite Safety Drama, Sarepta Beats Q2 Estimates—But No Thanks to Elevidys Sales
August 7, 2025
·
2 min read
·
Tristan Manalac